Related Experiment Video
Updated: Aug 9, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A case of hypertrophic cardiomyopathy with untoward outcome
1Consultant Cardiologist, Medway Maritime Hospital, Gillingham.
Insights
Sudden cardiac death (SCD) risk in hypertrophic cardiomyopathy (HCM) is hard to predict. A case study shows current risk scores, including the European Society of Cardiology (ESC) system, may miss patients needing an implantable cardiac defibrillator (ICD).
Area of Science:
- Cardiology
- Genetics
- Preventive Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition.
- Sudden cardiac death (SCD) is a major risk for HCM patients.
- Current methods for identifying high-risk HCM patients are insufficient.
Abstract:
Risk stratification for sudden cardiac death (SCD) and the selection of patients for prophylactic implantable cardiac defibrillator (ICD) in hypertrophic cardiomyopathy (HCM) are still evolving and far from ideal. I present a historical case of HCM that did not have recognised SCD risk factors. This case highlights the deficiency of the present risk-stratification strategy for HCM and European Society of Cardiology (ESC) risk-scoring system.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
